Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice.

Abstract:

:Epidemiologic studies have correlated elevated plasma fibrinogen (hyperfibrinogenemia) with risk of cardiovascular disease and arterial and venous thrombosis. However, it is unknown whether hyperfibrinogenemia is merely a biomarker of the proinflammatory disease state or is a causative mechanism in the etiology. We raised plasma fibrinogen levels in mice via intravenous infusion and induced thrombosis by ferric chloride application to the carotid artery (high shear) or saphenous vein (lower shear); hyperfibrinogenemia significantly shortened the time to occlusion in both models. Using immunohistochemistry, turbidity, confocal microscopy, and elastometry of clots produced in cell and tissue factor-initiated models of thrombosis, we show that hyperfibrinogenemia increased thrombus fibrin content, promoted faster fibrin formation, and increased fibrin network density, strength, and stability. Hyperfibrinogenemia also increased thrombus resistance to tenecteplase-induced thrombolysis in vivo. These data indicate that hyperfibrinogenemia directly promotes thrombosis and thrombolysis resistance and does so via enhanced fibrin formation and stability. These findings strongly suggest a causative role for hyperfibrinogenemia in acute thrombosis and have significant implications for thrombolytic therapy. Plasma fibrinogen levels may be used to identify patients at risk for thrombosis and inform thrombolytic administration for treating acute thrombosis/thromboembolism.

journal_name

Blood

journal_title

Blood

authors

Machlus KR,Cardenas JC,Church FC,Wolberg AS

doi

10.1182/blood-2010-11-316885

subject

Has Abstract

pub_date

2011-05-05 00:00:00

pages

4953-63

issue

18

eissn

0006-4971

issn

1528-0020

pii

blood-2010-11-316885

journal_volume

117

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Mechanism of quinine-dependent monoclonal antibody binding to platelet glycoprotein IIb/IIIa.

    abstract::Drug-dependent antibodies (DDAbs) that cause acute thrombocytopenia upon drug exposure are nonreactive in the absence of the drug but bind tightly to a platelet membrane glycoprotein, usually α(IIb)/β3 integrin (GPIIb/IIIa) when the drug is present. How a drug promotes binding of antibody to its target is unknown and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-04-643148

    authors: Bougie DW,Peterson J,Rasmussen M,Aster RH

    更新日期:2015-10-29 00:00:00

  • Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS.

    abstract::Recent population-based studies demonstrate an increased fracture risk with monoclonal gammopathy of undetermined significance (MGUS). The etiology of this increased risk remains unclear, however, because areal bone mineral density (aBMD) measurements by dual-energy x-ray absorptiometry cannot assess bone microstructu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-04-351437

    authors: Ng AC,Khosla S,Charatcharoenwitthaya N,Kumar SK,Achenbach SJ,Holets MF,McCready LK,Melton LJ 3rd,Kyle RA,Rajkumar SV,Drake MT

    更新日期:2011-12-15 00:00:00

  • Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment.

    abstract::Arsenic trioxide (As₂O₃) is a highly effective treatment for patients with refractory/relapsed acute promyelocytic leukemia (APL), but resistance to As₂O₃ has recently been seen. In the present study, we report the findings that 2 of 15 patients with refractory/relapsed APL treated with As₂O₃ were clinically As₂O₃ res...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-329433

    authors: Goto E,Tomita A,Hayakawa F,Atsumi A,Kiyoi H,Naoe T

    更新日期:2011-08-11 00:00:00

  • The effect of Hydrocortisone on the kinetics of normal human lymphocytes.

    abstract::Lymphocyte kinetic studies employing 51-chromium-labeled autologous lymphocytes were performed in nine normal volunteers in order to determine the effects of hydrocortisone administration on the recirculating versus the nonrecirculating intravascular lymphocyte pools. Following infusion of labeled cells, the recircula...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fauci AS,Dale DC

    更新日期:1975-08-01 00:00:00

  • G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation.

    abstract::Recently G alpha 16, a new guanosine triphosphate (GTP) binding protein alpha subunit has been described to be specifically expressed in human hematopoietic cells. Expression of G alpha 16 was observed in human cell lines of myelomonocytic and T-lymphocytic origin, but not in human B-cell lines Raji and IM9. We studie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mapara MY,Bommert K,Bargou RC,Leng C,Beck C,Ludwig WD,Gierschik P,Dörken B

    更新日期:1995-04-01 00:00:00

  • Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.

    abstract::In eighty-three patients with confirmed deep vein thrombosis, the fibrinolytic system was studied before and after a 10-minute venous occlusion. Blood was collected at least 3 months after the last acute episode, and PAI-1 antigen and activity, as well as tissue-type plasminogen activator (t-PA) antigen, urokinase-typ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nguyen G,Horellou MH,Kruithof EK,Conard J,Samama MM

    更新日期:1988-08-01 00:00:00

  • Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis.

    abstract::Hemojuvelin (HJV) positively modulates the iron regulator hepcidin, and its mutations are the major cause of juvenile hemochromatosis (JH), a recessive disease leading to iron overload. Defective HJV reduces hepcidin up-regulation both in humans and in Hjv-deficient mice. To investigate the JH pathogenesis and the fun...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-041004

    authors: Silvestri L,Pagani A,Fazi C,Gerardi G,Levi S,Arosio P,Camaschella C

    更新日期:2007-05-15 00:00:00

  • Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disea

    abstract::T cell-depleted haploidentical hematopoietic stem cell transplantation (haploHSCT) is an option to treat children with very high-risk acute lymphoblastic leukemia (ALL) lacking an HLA-identical donor. We analyzed 127 children with ALL who underwent haploHSCT in first (n = 22), second (n = 48), or third (n = 32), compl...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2009-03-207001

    authors: Klingebiel T,Cornish J,Labopin M,Locatelli F,Darbyshire P,Handgretinger R,Balduzzi A,Owoc-Lempach J,Fagioli F,Or R,Peters C,Aversa F,Polge E,Dini G,Rocha V,Pediatric Diseases and Acute Leukemia Working Parties of the Europe

    更新日期:2010-04-29 00:00:00

  • A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia.

    abstract::A noninferiority study was performed comparing low-dose and standard-dose prophylactic platelet transfusions. A double-blind randomized controlled trial (RCT) was performed in 6 sites in 3 countries. Thrombocytopenic adults requiring prophylactic platelet transfusion were randomly allocated to standard-dose (300-600 x...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2008-09-178236

    authors: Heddle NM,Cook RJ,Tinmouth A,Kouroukis CT,Hervig T,Klapper E,Brandwein JM,Szczepiorkowski ZM,AuBuchon JP,Barty RL,Lee KA,SToP Study Investigators of the BEST Collaborative.

    更新日期:2009-02-12 00:00:00

  • Distinct HLA associations by stroke subtype in children with sickle cell anemia.

    abstract::Children with sickle cell anemia (SCA) carry a 200-fold increased risk for cerebral infarction. Stroke can be the result of small-vessel (SV) or large-vessel (LV) disease. However, it is unknown whether these subtypes result from the same pathophysiologic processes. Complete HLA genotyping was performed on 231 eligibl...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2002-09-2791

    authors: Hoppe C,Klitz W,Noble J,Vigil L,Vichinsky E,Styles L

    更新日期:2003-04-01 00:00:00

  • Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1.

    abstract::The production of interleukin-1beta (IL-1beta), a powerful mediator of inflammation, is tightly regulated at several levels. However, in some pathologic conditions, a pharmacologic treatment is required to control the toxicity of excessive extracellular IL-1beta. Because of the heavy side effects of most therapies use...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hamon Y,Luciani MF,Becq F,Verrier B,Rubartelli A,Chimini G

    更新日期:1997-10-15 00:00:00

  • Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL.

    abstract::Spontaneous regression is a recognized phenomenon in chronic lymphocytic leukemia (CLL) but its biological basis remains unknown. We undertook a detailed investigation of the biological and clinical features of 20 spontaneous CLL regression cases incorporating phenotypic, functional, transcriptomic, and genomic studie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001262

    authors: Kwok M,Oldreive C,Rawstron AC,Goel A,Papatzikas G,Jones RE,Drennan S,Agathanggelou A,Sharma-Oates A,Evans P,Smith E,Dalal S,Mao J,Hollows R,Gordon N,Hamada M,Davies NJ,Parry H,Beggs AD,Munir T,Moreton P,Paneesha

    更新日期:2020-02-06 00:00:00

  • Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants.

    abstract::Because of continuous blood transfusions, thalassemia patients are subjected to peroxidative tissue injury by the secondary iron overload. In accordance, analysis of serum from 42 beta-thalassemia patients, aged 4 to 40 years, showed that the mean concentrations of conjugated diene lipid hydroperoxides (CD), lipoperox...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Livrea MA,Tesoriere L,Pintaudi AM,Calabrese A,Maggio A,Freisleben HJ,D'Arpa D,D'Anna R,Bongiorno A

    更新日期:1996-11-01 00:00:00

  • Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B.

    abstract::Gene therapy for hemophilia B aims to ameliorate bleeding risk and provide endogenous factor IX (FIX) activity/synthesis through a single treatment, eliminating the requirement for FIX concentrate. AMT-060 combines an adeno-associated virus-5 (AAV5) vector with a liver-specific promoter driving expression of a codon-o...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2017-09-804419

    authors: Miesbach W,Meijer K,Coppens M,Kampmann P,Klamroth R,Schutgens R,Tangelder M,Castaman G,Schwäble J,Bonig H,Seifried E,Cattaneo F,Meyer C,Leebeek FWG

    更新日期:2018-03-01 00:00:00

  • Dominant-negative C/ebpα and polycomb group protein Bmi1 extend short-lived hematopoietic stem/progenitor cell life span and induce lethal dyserythropoiesis.

    abstract::The primitive hematopoietic stem/progenitor cells (HSPCs) during embryonic hematopoiesis are thought to be short-lived (SL) with limited self-renewal potential. The fate and consequence of these short-lived HSPCs, once reprogrammed into "long-lived" in a living animal body, remain unknown. Here we show that targeted e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-327908

    authors: Zhou T,Wang L,Zhu KY,Dong M,Xu PF,Chen Y,Chen SJ,Chen Z,Deng M,Liu TX

    更新日期:2011-10-06 00:00:00

  • Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC-55494) after radiation-induced bone marrow aplasia.

    abstract::The synthetic cytokine (Synthokine) SC-55494 is a high-affinity interleukin-3 (IL-3) receptor ligand that stimulates greater in vitro multilineage hematopoietic activity than native IL-3, while inducing no significant increase in inflammatory activity relative to native IL-3. The aim of this study was to investigate t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Farese AM,Herodin F,McKearn JP,Baum C,Burton E,MacVittie TJ

    更新日期:1996-01-15 00:00:00

  • A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity.

    abstract::Human hematopoietic progenitor cells express L-selectin and also express PSGL-1, a ligand for all selectins. Using a shear-based adhesion assay, a hematopoietic cell L-selectin ligand (HCLL) that is expressed on the hematopoietic cell line KG1a and on normal human hematopoietic progenitors was previously identified. T...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sackstein R,Dimitroff CJ

    更新日期:2000-10-15 00:00:00

  • Histamine induces interleukin-8 secretion by endothelial cells.

    abstract::It has been shown that histamine induces early changes on endothelial cells (EC), such as a transient expression of P-selectin and secretion and/or surface expression of early mediators (eg, prostacyclin [PG1(2)], platelet-activating factor [PAF], and leukotriene B4 [LTB4]). However, delayed effects of histamine on EC...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jeannin P,Delneste Y,Gosset P,Molet S,Lassalle P,Hamid Q,Tsicopoulos A,Tonnel AB

    更新日期:1994-10-01 00:00:00

  • Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.

    abstract::Type 3 von Willebrand disease (VWD) is a severe hemorrhagic defect in humans. We now identify the homozygous mutation in the Chapel Hill strain of canine type 3 VWD that results in premature termination of von Willebrand factor (VWF) protein synthesis. We cultured endothelium from VWD and normal dogs to study intracel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0464

    authors: Haberichter SL,Merricks EP,Fahs SA,Christopherson PA,Nichols TC,Montgomery RR

    更新日期:2005-01-01 00:00:00

  • Antihuman plasma glutathione peroxidase antibodies: immunologic investigations to determine plasma glutathione peroxidase protein and selenium content in plasma.

    abstract::Plasma glutathione peroxidase (GSHPx) (glutathione: H2O2 oxidoreductase) is a unique selenoglycoprotein. Treatment of this enzyme with glycopeptidase F partially deglycosylates it and establishes the presence of N-linked sugar moieties. Antibodies raised in a rabbit against the purified enzyme from plasma were found t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Avissar N,Whitin JC,Allen PZ,Palmer IS,Cohen HJ

    更新日期:1989-01-01 00:00:00

  • Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice.

    abstract::Oxygen-induced retinopathy (OIR) is a well-characterized model for retinopathy of prematurity, a disorder that results from rapid microvascular proliferation after exposure of the retina to high oxygen levels. Here, we report that the proliferative phase of OIR requires transcriptional induction of the annexin A2 (A2)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-341214

    authors: Huang B,Deora AB,He KL,Chen K,Sui G,Jacovina AT,Almeida D,Hong P,Burgman P,Hajjar KA

    更新日期:2011-09-08 00:00:00

  • Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells.

    abstract::Bortezomib (PS-341), a selective inhibitor of proteasomes, induces apoptosis in multiple myeloma (MM) cells; however, prolonged drug exposure may result in cumulative toxicity and the development of chemoresistance. Here we show that combining PK-11195 (PK), an antagonist to mitochondrial peripheral benzodiazepine rec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0547

    authors: Chauhan D,Li G,Podar K,Hideshima T,Mitsiades C,Schlossman R,Munshi N,Richardson P,Cotter FE,Anderson KC

    更新日期:2004-10-15 00:00:00

  • Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.

    abstract::Male recipients of transplants from female (F-->M) hematopoietic stem cell donors represent a special group in whom donor T cells that are specific for recipient minor histocompatibility antigens encoded by Y-chromosome genes may contribute to a graft-versus-leukemia (GVL) effect and to graft-versus-host disease (GVHD...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2603

    authors: Randolph SS,Gooley TA,Warren EH,Appelbaum FR,Riddell SR

    更新日期:2004-01-01 00:00:00

  • AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice.

    abstract::Emerging successful clinical data on gene therapy using adeno-associated viral (AAV) vector for hemophilia B (HB) showed that the risk of cellular immune response to vector capsid is clearly dose dependent. To decrease the vector dose, we explored AAV-8 (1-3 × 10(12) vg/kg) encoding a hyperfunctional factor IX (FIX-Pa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-588194

    authors: Crudele JM,Finn JD,Siner JI,Martin NB,Niemeyer GP,Zhou S,Mingozzi F,Lothrop CD Jr,Arruda VR

    更新日期:2015-03-05 00:00:00

  • Two-faced T cells in CLL.

    abstract::In this issue of Blood, Bagnara et al describe the development of a reliable and convincing xenograft model of CLL that recapitulates aspects of the leukemic microenvironment and gives intriguing insights into disease biology. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2011-03-342709

    authors: Devereux S

    更新日期:2011-05-19 00:00:00

  • Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78.

    abstract::One hundred fifty-one children with acute myelogenous leukemia (AML) entered the cooperative study BFM-78 between December 1978 and October 1982. The initial therapy consisted of an intensive induction and consolidation regimen over eight weeks with seven different drugs and cranial irradiation. It was followed by mai...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Creutzig U,Ritter J,Riehm H,Langermann HJ,Henze G,Kabisch H,Niethammer D,Jürgens H,Stollmann B,Lasson U

    更新日期:1985-02-01 00:00:00

  • Circulating forms of intercellular adhesion molecule (ICAM)-1 in mice lacking membranous ICAM-1.

    abstract::Mice deficient in intercellular adhesion molecule-1 (ICAM-1), lacking membranous ICAM-1, show a normal development but abnormalities of inflammatory and immune functions. Although the membrane-bound form of ICAM-1 is not detectable in the mutant strain, circulating ICAM-1 (cICAM) is present in serum from ICAM-1-defici...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Den Engel NK,Heidenthal E,Vinke A,Kolb H,Martin S

    更新日期:2000-02-15 00:00:00

  • Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.

    abstract::Hemophilic bleeding into joints causes synovial and microvascular proliferation and inflammation (hemophilic synovitis) that contribute to end-stage joint degeneration (hemophilic arthropathy), the major morbidity of hemophilia. New therapies are needed for joint deterioration that progresses despite standard intraven...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-131417

    authors: Sun J,Hakobyan N,Valentino LA,Feldman BL,Samulski RJ,Monahan PE

    更新日期:2008-12-01 00:00:00

  • Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis.

    abstract::Dosing of enzyme replacement therapy (ERT) for Gaucher disease type 1 is still a subject of debate and varies from 15 to 130 U/kg/mo, making a huge economic difference of 70,000 US dollars to 380,000 US dollars(euro55,000-300,000) per patient per year. To investigate whether this difference in dosing ultimately transl...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2005-12-5072

    authors: de Fost M,Hollak CE,Groener JE,Aerts JM,Maas M,Poll LW,Wiersma MG,Häussinger D,Brett S,Brill N,vom Dahl S

    更新日期:2006-08-01 00:00:00

  • Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials.

    abstract::While investigating 2592 patients enrolled in multicenter myeloma trials, we found light chain-only (LCO) patients had worse median survival times (1.9 years) than patients with IgA and IgG paraproteins (2.3 and 2.5 years, respectively) (P < .001). However, IgA and IgG patients with levels of LC excretion similar to t...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2006-03-008953

    authors: Drayson M,Begum G,Basu S,Makkuni S,Dunn J,Barth N,Child JA

    更新日期:2006-09-15 00:00:00